RheoCarti is developing a new generation of joint implants designed to mimic the properties of natural cartilage.
RheoCarti has raised €158k across 1 funding round from 1 investor, most recently a round in Sep 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 29 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-29 | Other | €158k |
| Venture Kick |
| View deal → |
